98%
921
2 minutes
20
Background And Purpose: There is an imperfect correlation between morphological MRI findings and radiating low back pain. Nerve irritation, visualized as glucose hypermetabolism on [F]FDG-PET/MRI, has the potential to identify symptomatic segments. This study aimed to investigate the association of foraminal [F]FDG uptake on PET/MRI, radiological abnormalities and patient outcomes.
Materials And Methods: Prospectively recruited patients with radiating low back pain underwent [F]FDG PET/MRI of the lumbar spine in this observational study. Back pain and leg/buttock pain were assessed using the visual analog scale (0-10). Foraminal stenosis, facet joint arthropathy, and annular fissures of the disc were graded by radiologists. As part of the standard clinical care, a subset of patients received image-guided nerve root blocks, using a steroid/anesthetic mixture, and pain on visual analog scale was noted before and after injection. Standardized tracer uptake was quantitatively assessed in all neural foramina, facet joints, and discs. Generalized estimating equations were used to investigate associations between the maximum standardized uptake value of [F]FDG in the neural foramina, degree of stenosis (none, mild, moderate, severe), and pain, additionally adjusted for tracer uptake in the adjacent tissues, age, sex, and body mass index.
Results: A total of 110 lumbar neural foramina in 11 patients were included in the analysis. Generalized estimating equations revealed significant associations between foraminal [F]FDG uptake and degree of foraminal stenosis (beta 0.18, 95%CI 0.03, 0.33, p=0.02). In patients with unilateral radicular symptoms but bilateral stenoses on MRI, [F]FDG uptake was significantly higher on the symptomatic side (1.64 vs. 1.88, p=0.002). In segments treated with image-guided nerve root block, change in pain was positively associated with foraminal [F]FDG uptake before injection (beta 2.24, 95%CI 0.03, 4.45, p=0.05) but negatively associated with degree of stenosis (beta -1.27, 95%CI -2.24, -0.31, p=0.01).
Conclusions: Foraminal [F]FDG uptake on PET/MRI as a surrogate marker of nerve irritation may improve differentiation between painful vs. non-painful foraminal stenosis.
Abbreviations: LBP = Low back pain, SUVmax = Maximum standardized uptake value.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3174/ajnr.A8974 | DOI Listing |
J Cereb Blood Flow Metab
September 2025
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Preclinical PET studies offer the opportunity to elucidate molecular mechanisms underlying early neurodevelopment with minimal invasiveness. We demonstrated the feasibility of fetal brain PET in four pregnant rats ( = 42 fetuses). [F]FDG uptake in rat fetuses was readily visualized by PET imaging.
View Article and Find Full Text PDFNucl Med Biol
September 2025
Department of Nuclear Medicine, Hannover Medical School, Germany. Electronic address:
Purpose: The liver-brain axis regulates metabolic homeostasis, with glucose metabolism playing a key role. Liver dysfunction, such as fibrosis, may impact brain metabolism and consequently, brain function. Positron emission tomography (PET) imaging provides a non-invasive approach to study glucose metabolism in both organs.
View Article and Find Full Text PDFCancer Immunol Immunother
September 2025
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CHUV/UNIL, 1011, Lausanne, Switzerland.
Background: Immunotherapy is a mainstay in the treatment of patients with advanced melanoma. Yet, resistance mechanisms exist, and tumour-associated macrophages (TAMs), particularly the M2-like phenotype, are associated with poorer outcomes, with CD206 serving as their specific marker. We present the first human SPECT/CT study to visualize CD206 + TAMs in patients undergoing immunotherapy and compare the findings to clinical outcomes (NCT04663126).
View Article and Find Full Text PDFMol Imaging Radionucl Ther
September 2025
University Clinical Center of Serbia, Center for Nuclear Medicine with PET, Belgrade, Serbia.
Fluorine-fluorocholine (F-FCH) is a radiopharmaceutical used in primary hyperparathyroidism. The data about its utility in malignancies other than prostate and hepatocellular carcinoma is limited. We present the case of a patient who was referred for F-FCH positron emission tomography/computed tomography (PET/CT) due to the persistently elevated parathormone and calcium levels following total thyroidectomy with left lower parathyroidectomy for parathyroid carcinoma (PTC).
View Article and Find Full Text PDFFront Oncol
August 2025
German Center for Lung Research (Deutsches Zentrum für Lungenforschung (DZL)) (Comprehensive Pneumology Center - Munich (CPC-M)), Munich, Germany.
Background: Predictors for checkpoint inhibitor-related pneumonitis (cinrPneumonitis) are desperately needed. This study aimed to investigate the pretreatment standardized uptake value (SUV) on [F]FDG-PET/CT of non-tumorous lung tissue as a predictive imaging marker for the development of cinrPneumonitis in 239 patients with lung cancer.
Methods: All patients with lung cancer receiving [F]Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) prior to immune checkpoint inhibitor (ICI) therapy were included and retrospectively analyzed.